Evoxa vs Sarpkaya
Price, ratings, monetisation and update history for both apps, side by side β with what reviewers say about each.
Evoxa
Read full descriptionHide full description
Evoxa helps you explore England respiratory health statistics from the UK Health Security Agency (UKHSA) on iPhone. It uses the official public API to deliver charts, a personal watchlist, and export tools built for mobile. KEY FEATURES - Dashboard: star and reorder favorite metrics; open full charts in one tap - Insights: all indicators at a glance; sort and filter week-over-week movers - Compare: overlay two metrics; drag for dual readouts on an indexed chart - Explorer: add UKHSA respiratory indicators beyond the 12 presets - Widget and local alerts for pinned or starred metrics - CSV export, PNG sharing, and on-device cache with stale-data banner METRICS Line charts with search, sex/age filters, and time ranges (4W, 12W, 1Y, All). Drag to inspect points. Twelve built-in indicators cover influenza, RSV, NHS 111 calls, COVID PCR, and related series. INSIGHTS AND DASHBOARD Snapshot cards with trend direction and week-over-week notes. Tap through to Metrics. Favorites support 7d, 28d, and 1y change windows.
Sarpkaya
Read full descriptionHide full description
Sarpkaya is a clean market companion for iPhone. The Dashboard summarizes market overview, your watchlist, and quick symbol search. Markets helps you browse US stocks and ETFs, filter by category, and manage favorites. Each quote page shows price, change, and day range, with optional price alerts via local notifications. Quotes can be cached on your device for offline reference. A Home Screen widget highlights a symbol from your watchlist and opens the app in one tap. Settings stay simple: notifications and refresh. No account required. No ads. Market information is for reference onlyβnot investment advice.
Screenshots
Verdict
Evoxa and Sarpkaya are too close to call on the numbers: across 5 compared parameters β price, ads, in-app purchases and device support among them β neither pulls far enough ahead to decide it. What separates them is feature set and interface, not measurable difference.
Scored on Price Β· Rating Β· Positive reviews Β· Number of ratings Β· Update frequency Β· Ads Β· In-app purchases Β· Monetization Β· Best chart rank Β· Devices Β· Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
| Parameter | Evoxa | Sarpkaya |
|---|---|---|
| Price | Free | Free |
| Update frequency | β | Every 9 days |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPhone | iPhone |
| Requires iOS | 16.0 | 16.0 |
| Further details β not scored | ||
| Size | 4 MB | 1 MB |
| Age rating | 17+ | 17+ |
| Developer | ARSLAN SERAFETTIN | AKDENIZ MUSTAFA |
In-app purchases
Evoxa
No in-app purchases
Sarpkaya
No in-app purchases






